Transce3nd’s Boston Scientific BSX Stock Holding History

Transce3nd’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-135	Closed	-$14.5K	–	287
2025 Q2	$14.5K	Hold	135	–	–	0.01%	505
2025 Q1	$13.6K	Sell	135 -1,540	-92%	-$155K	0.01%	506
2024 Q4	$150K	Buy	+1,675	New	+$147K	0.05%	203

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Transce3nd's BSX Position: Q3 2025 in Review

Transce3nd sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 135 shares — an estimated $14.5K sold.

Transce3nd first reported a position in BSX in Q4 2024 and held it in 3 quarters. The position peaked at $150K in Q4 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Transce3nd reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 135 Boston Scientific shares in Q3 2025, an estimated $14.5K.
Transce3nd first reported a position in Boston Scientific in Q4 2024 and held it in 3 quarters.
Transce3nd's Boston Scientific position peaked at $150K in Q4 2024.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.